MSN Laboratories Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • MSN Laboratories's estimated annual revenue is currently $7.5M per year.(i)
  • MSN Laboratories's estimated revenue per employee is $1,938

Employee Data

  • MSN Laboratories has 3870 Employees.(i)
  • MSN Laboratories grew their employee count by 25% last year.

MSN Laboratories's People

NameTitleEmail/Phone
1
Executive OfficerReveal Email/Phone
2
Associate VPReveal Email/Phone
3
Head ProductionReveal Email/Phone
4
Sales Business officerReveal Email/Phone
5
HVAC OFFICERReveal Email/Phone
6
Head Finance North AmericaReveal Email/Phone
7
Regulatory Affairs OfficerReveal Email/Phone
8
head sourcingReveal Email/Phone
9
Head Packaging DevelopmentReveal Email/Phone
10
Head - Marketing ExcellenceReveal Email/Phone

What Is MSN Laboratories?

Founded in 2003, the Hyderabad based MSN Labs is one of the fastest growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products in the market and in the pipeline, MSN has 9 API and 5 Finished Dosage facilities (including Oncology) and an integrated R&D Centre. MSN has won the trust of more than 250 customers across 65 countries around the globe covering US, Europe, Latin America, Middle-East, Asia Pacific, Africa and CIS markets. Our product basket offers over 250 APIs & 120 Formulations covering 35 major therapies. Innovation & speed form the core of our business strategy. Pro-active marketing, robust IP strategy, innovative R&D expertise, dynamic SCM, insight driven IT and world class capabilities are our ingredients to success. With a dedicated & experienced team of over 6000, the work environment at MSN integrates multiple disciplines and functions by exhaustive communication of goals and objectives through technology and values of Integrity, Imagination & Innovation. With an outstanding workforce, cutting-edge science, state-of-the-art technology and knowledge intensive initiatives, we are working on innovative solutions for tomorrow`s healthcare challenges.

keywords:N/A

N/A

Total Funding

3870

Number of Employees

$7.5M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MSN Laboratories News

2022-04-20 - Wilson's Disease Market Size, Outlook And Forecast | Bausch ...

... Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, ANI Pharmaceuticals, APOTEX, Tsumura, Sinepharm, Taj Pharmaceutical.

2022-04-17 - Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited

Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited. Tue, April 19, 2022,...

2022-04-17 - FDA Updates for the Week of April 18, 2022

The generic product was developed and will be manufactured by MSN Laboratories and marketed by Breckenridge in the United States.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M39026%N/A
#2
$1240.4M581015%N/A
#3
$1448.8M7392N/AN/A
#4
$964.3M98408%N/A
#5
$9872.3M6981811%N/A